InflaRx (IFRX) Revenue (2018 - 2026)
InflaRx (IFRX) posted Revenue of -$1.9 million for Q1 2026, down 103.34% sequentially from $56.1 million in Q4 2025, and down 5042.93% YoY from $37906.8 in Q1 2025.
InflaRx (IFRX) Revenue (2018 - 2026) Analysis & Trends
InflaRx has reported Revenue for 9 years, with the latest figure at -$1.9 million in Q1 2026.
- Quarterly Revenue fell 5042.93% year-over-year to -$1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.3 million (down 4.14% YoY) and the FY2025 annual result came in at $54.5 million, down 4.97% from the prior year.
- Revenue fell to -$1.9 million in Q1 2026 per IFRX's latest filing, from $56.1 million in the prior quarter.
- Over five years, Revenue peaked at $66.2 billion in Q3 2023 and troughed at -$1.9 million in Q1 2026.
- A 5-year average of $4.2 billion and a median of $44635.4 in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2023 and 2026: Revenue surged 9861149.48% in 2023, then plunged 5042.93% in 2026.
- Over 5 years, Revenue stood at $339417.9 in 2022, then surged by 14116.39% to $48.3 million in 2023, then gained by 17.02% to $56.5 million in 2024, then fell by 0.65% to $56.1 million in 2025, then plunged by 103.34% to -$1.9 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered -$1.9 million, $56.1 million, and $27858.6 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 674.14 Mn |
| 10 | InflaRx | 139.62 Mn | -44.63 Mn | 2.74 Bn | 45,788.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.87 Mn |
| Dec 31, 2025 | 56.10 Mn |
| Sep 30, 2025 | 27,858.58 |
| Jun 30, 2025 | 44,635.43 |
| Mar 31, 2025 | 37,906.76 |
| Dec 31, 2024 | 56.47 Mn |
| Sep 30, 2024 | 135,980.44 |
| Jun 30, 2024 | 6,845.77 |
| Mar 31, 2024 | 39,149.22 |
| Dec 31, 2023 | 48.25 Mn |
| Sep 30, 2023 | 66.19 Bn |
| Jun 30, 2023 | -1.81 Mn |
| Mar 31, 2023 | 5.33 Bn |
| Dec 31, 2022 | 339,417.93 |
| Sep 30, 2022 | -671,222.34 |
| Jun 30, 2022 | 15.85 Mn |
| Mar 31, 2022 | -934,045.36 |
| Dec 31, 2021 | -7.30 Bn |
| Sep 30, 2021 | -787,910.16 |
| Jun 30, 2021 | 16.84 Mn |